Cancer
ROCHESTER, Minn. — A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment,[...]
Latest stories
Biotherapeutics
April 9, 2024
Health & Wellness
April 4, 2024
Transplant
April 1, 2024
Research
April 1, 2024
Neurosciences
April 1, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community